Human papillomavirus-induced cutaneous and mucosal lesions in a patient with rothmund-thomson syndrome
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Acta dermato-venereologica. - 100, 15 (2020) , adv00252, ISSN: 1651-2057
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- Urheber
-
Kuntz, Thomas
Koushk Jalali, Bijan
Tigges, Christian
Silling, Steffi
Oellig, Frank
Has, Cristina
Hampl, Monika
Wieland, Ulrike
Kreuter, Alexander
- DOI
-
10.2340/00015555-3596
- URN
-
urn:nbn:de:bsz:25-freidok-1753674
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuntz, Thomas
- Koushk Jalali, Bijan
- Tigges, Christian
- Silling, Steffi
- Oellig, Frank
- Has, Cristina
- Hampl, Monika
- Wieland, Ulrike
- Kreuter, Alexander
- Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Rothmund–Thomson syndrome type 1 caused by biallelic ANAPC1 gene mutations
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Dupilumab improves congenital ichthyosis
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Selected genodermatoses – Status quo and future prospects
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Rothmund-Thomson syndrome
Rothmund–Thomson syndrome type 1 caused by biallelic ANAPC1 gene mutations
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Dupilumab improves congenital ichthyosis
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Selected genodermatoses – Status quo and future prospects
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review
Rothmund-Thomson syndrome
Rothmund–Thomson syndrome type 1 caused by biallelic ANAPC1 gene mutations
Dupilumab bessert kongenitale Ichthyose : = Dupilumab improves congenital ichthyosis
Advances in understanding the molecular basis of skin fragility
Dupilumab improves congenital ichthyosis
Strategy for the optimization of read-through therapy for junctional epidermolysis bullosa with COL17A1 nonsense mutation
Secukinumab for the treatment of SAM syndrome associated with desmoglein‐1 deficiency
Ausgewählte Genodermatosen – Stand der Dinge und Zukunftsaussichten
Update on genetic conditions affecting the skin and the kidneys
Selected genodermatoses – Status quo and future prospects
Molecular therapeutics in development for Epidermolysis bullosa: update 2020
Treatment of epidermolysis bullosa and future directions: a review